We have demonstrated that the stage 1, state of increased risk for T1D development in nondiabetic FDRs of patients with T1D, is associated with the lowest CD25highT cells and diminished TGFβ1, partially reflecting impaired T regulatory response. This evidence concerns the gene TGFB1 and type 1 diabetes mellitus.